Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01626300
Other study ID # 200513884
Secondary ID
Status Completed
Phase N/A
First received June 20, 2012
Last updated June 19, 2017
Start date December 2007
Est. completion date June 2008

Study information

Verified date May 2017
Source University of California, Davis
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to determine if the daily use of a certain amount and type of milk component for 2 months provides a significant stimulation to the immune system and specifically increases the chances of being protected against pneumonia after the vaccination.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date June 2008
Est. primary completion date June 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria:

- Age and a willingness to participate

Exclusion Criteria:

- • Smoking history within 10 years

- Underlying neoplasia or immunological disease

- Use of oral cortisone or other immunosuppressive agents

- Current consumption of milk and milk products greater than 1 unit of milk, 1 yogurt, or 1 serving of fresh cheese a day.

- Food faddists or those taking a non-traditional diet

- Current consumption of dietary supplements

- People with a known history of milk allergy

- People with chronic renal failure

- People with chronic inflammatory diseases taking daily doses of NSAIDs for longer than 4 weeks at the time of enrollment.

- Previous administration of the pneumomax vaccine

- Reduced physical activity (i.e. NYHA classes III-IV)

Study Design


Related Conditions & MeSH terms

  • Pneumonia
  • The Effect of Milk Components on the Response to Pneumococcal Vaccines in the Elderly

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of California, Davis